Access cutting-edge systemic sclerosis treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.
Access systemic sclerosis specialists in Pittsburgh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related systemic sclerosis treatment provided free
The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published regimens in SSc patients, while maintaining a treatment effect.
Sponsor: Paul Szabolcs
Check if you qualify for this systemic sclerosis clinical trial in Pittsburgh, PA
If you're searching for systemic sclerosis treatment options in Pittsburgh, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.